Furthermore, we found that the TES promoter was frequently hypermethylated in primary GC tissues and GC cell lines, and the protein expression of TES was significantly decreased in 72% GC tissues as compared with matched non-tumor tissues [3]. The gene discussed is TES; the disease is neoplasm.